We’re the PCR experts: leading the industry on quality, performance, value and customer service.
For information on PCR reagents for COVID-19 detection, please email info@pcrbio.com or call us on +44 (0) 203 930 8101.
Press Release
PCR Biosystems introduces kit for reliable quantification of libraries prepared for Illumina® NGS systems
PCR Biosystems, the UK-based PCR experts, have expanded their range of specialist molecular biology kits with the introduction of NGSBIO Library Quant Kit for Illumina®.
The new kit contains all the components necessary for accurate and sensitive quantification of DNA libraries prior to next generation sequencing (NGS) with Illumina platforms. Employed for the vast majority of NGS, the Illumina system requires quantification of libraries prior to sequencing to ensure the correct amount of library is loaded into the machine. This is essential for generating the maximum amount of clustering data possible per run, saving valuable time and money.
Read More
Press Release
New leap forward for SARS-CoV-2 detection
PCR Biosystems launches 4x RT-qPCR kit to enable ultra-sensitive, high-throughput detection of viral RNA sequences.
PCR Biosystems, the UK-based PCR experts, today announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2. The new kit, which marks the latest addition to PCR Biosystems’ specialized RT-qPCR offering, enables users to add more sample to their reactions to boost analytical sensitivity, even when working with small volume reactions.
Read More
Press Release
PCR Biosystems continues to scale up operations to meet demand
We are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 RT-qPCR tests remains available to the UK and global healthcare systems, as demand for testing rises.
Alex Wilson, Co-Founder of PCR Biosystems, explains, “These are unprecedented times, and, as a global PCR company, we are ideally placed to support the scientific and healthcare communities in their response to COVID-19. When the enormity of COVID-19 testing requirements became apparent, we immediately started scaling up production of the critical components. We already have capacity to supply 4 million reactions’ worth of reagent every day – and we have the option to scale up further if needed to ensure we can always meet global demand.”
Read More